Literature DB >> 12215830

Clinical features in 17 paediatric patients with Wegener granulomatosis.

Vladimir M Belostotsky1, Vanita Shah, Michael J Dillon.   

Abstract

The aim of this report was to describe childhood patients with Wegener granulomatosis (WG) from one centre, to analyse the variety of clinical manifestations seen and compare the data with other published paediatric and adult series. The records of 17 patients with WG who were under the care of Great Ormond Street Hospital for Children (GOSH) from 1981 to 1998 were reviewed. We analysed presenting features before admittance to GOSH and the clinical signs observed whilst the children were under the care of the hospital. Of 17 patients, 13 were females and there was a male/female ratio of 1:3.25. Among the patients there were 2 sisters. The age of the patients at disease onset varied from 2 weeks to 14 years. The median/mean age was 6/6.3 years. American College of Rheumatology criteria for diagnosing WG were fulfilled in 11 of 17 patients. The frequency of different system involvement was: respiratory 87%, kidneys 53%, sinuses 35%, joints 53%, eyes 53%, nervous system 12%, skin 53%. cANCA was positive in 10 patients (59%), but pANCA was negative in all measured sera. Kidneys were involved in 2 of 8 patients (25%) with the disease onset from 0 to 5 years and in 7 of 9 patients (78%) with the disease onset from 6 to 14 years ( P<0.05). cANCA was positive in 7 of 9 patients with kidney disease (78%) and in 2 of 8 patients (25%) without kidney involvement ( P<0.05). Colchicine as a supplement to prednisolone and cytotoxic/immunosuppressant drugs was used effectively in 5 patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12215830     DOI: 10.1007/s00467-002-0914-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  41 in total

Review 1.  ANCA-associated vasculitides-lessons from the adult literature.

Authors:  Joannis Vamvakopoulos; Caroline O Savage; Lorraine Harper
Journal:  Pediatr Nephrol       Date:  2010-04-01       Impact factor: 3.714

2.  ANCA-associated glomerulonephritis/systemic vasculitis in childhood: clinical features-outcome.

Authors:  Ekaterini Siomou; Despoina Tramma; Claire Bowen; David V Milford
Journal:  Pediatr Nephrol       Date:  2012-05-31       Impact factor: 3.714

Review 3.  Granulomatosis with polyangiitis in childhood.

Authors:  Marinka Twilt; Susanne Benseler; David Cabral
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

4.  EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides.

Authors:  S Ozen; N Ruperto; M J Dillon; A Bagga; K Barron; J C Davin; T Kawasaki; C Lindsley; R E Petty; A M Prieur; A Ravelli; P Woo
Journal:  Ann Rheum Dis       Date:  2005-12-01       Impact factor: 19.103

5.  Clinicopathological characteristics and outcomes of pediatric patients with systemic small blood vessel vasculitis.

Authors:  XiaoWei Li; ShaoShan Liang; ChunXia Zheng; CaiHong Zeng; HaiTao Zhang; WeiXin Hu; ZhiHong Liu
Journal:  Pediatr Nephrol       Date:  2014-07-16       Impact factor: 3.714

6.  Long- term outcome of paediatric patients with ANCA vasculitis.

Authors:  Nishkantha Arulkumaran; Susan Jawad; Stuart W Smith; Lorraine Harper; Paul Brogan; Charles D Pusey; Alan D Salama
Journal:  Pediatr Rheumatol Online J       Date:  2011-06-19       Impact factor: 3.054

7.  A unique neurological presentation of Wegener's granulomatosis.

Authors:  David Selewski; Suresh K Mukherji; David Kershaw
Journal:  Pediatr Nephrol       Date:  2010-03-02       Impact factor: 3.714

Review 8.  Vasculitis: do we know more to classify better?

Authors:  Ezgi Deniz Batu; Seza Ozen
Journal:  Pediatr Nephrol       Date:  2014-12-06       Impact factor: 3.714

9.  Chest CT findings in pediatric Wegener's granulomatosis.

Authors:  Daniel Levine; Jonathan Akikusa; David Manson; Earl Silverman; Rayfel Schneider
Journal:  Pediatr Radiol       Date:  2006-10-28

Review 10.  Ocular complications of childhood rheumatic diseases: nonuveitic inflammatory eye diseases.

Authors:  Andreas Reiff
Journal:  Curr Rheumatol Rep       Date:  2009-07       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.